欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/V/0141/001
药品名称BOVALTO Respi Intranasal
活性成分
    • Bovine parainfluenza 3 virus 7.0 log10 TCID50/d
    • bovine respiratory syncytial virus 6.0 log10 TCID50/d
剂型Lyophilisate and Solvent
上市许可持有人Boehringer Ingelheim Animal Health France SCS 29 Avenue Tony Garnier Lyon, 69007 France
参考成员国 - 产品名称Czechia (CZ)
BOVALTO RESPI INTRANASAL, nosní sprej, lyofilizát a rozpouštědlo pro suspenzi
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
      Bovalto Respi Intranasal
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
      BOVALTO RESPI INTRANASAL
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
    • Romania (RO)
许可日期2017/12/20
最近更新日期2023/06/24
药物ATC编码
    • QI02AD07 bovine respiratory syncytial virus + bovine parainfluenza virus
申请类型
  • TypeLevel1:food
  • TypeLevel2:Immunological
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase